Impact of vaccine mandates and removals on COVID-19 vaccine uptake in Australia and international comparators: a study protocol.

Publication date: Jul 07, 2025

Vaccination against SARS-CoV-2 was a crucial public health measure during the COVID-19 pandemic. Among the multiple strategies developed to increase vaccine uptake, governments often employed vaccine mandates. However, little evidence exists globally about the impact of these mandates and their subsequent removal on vaccine uptake, including in Australia, France, Italy and the USA. The aim of this study is to provide a protocol to evaluate and quantify the impact of COVID-19 vaccine mandates and removals on vaccine uptake in these countries, with a specific focus on comparing Australian policies with those from Europe and the USA. Actualising the work outlined in this protocol will help to provide policy and technical guidance for future pandemic preparedness and routine immunisation programmes. This protocol outlines a retrospective study using existing data sources including Australian Immunisation Register-Person Level Integrated Data Asset for Australia and publicly available data for France, Italy and California (USA). Causal inference methods such as interrupted time series, regression discontinuity design, difference-in-differences, matching and synthetic control will be employed to assess the estimated effects of vaccine mandates and removals on vaccine uptake. The University of Newcastle’s human research ethics committee has approved the study (reference number: H-2024-0160). Peer-reviewed papers will be submitted, and results will be presented at public health, immunisation and health economic conferences nationally and internationally. A lay summary will be published on the MandEval website.

Open Access PDF

Concepts Keywords
Australia Australia
Italy COVID-19
Vaccines COVID-19
Website COVID-19 Vaccines
COVID-19 Vaccines
Europe
Health Policy
Health policy
Humans
Immunization Programs
Italy
Mandatory Programs
Mandatory Vaccination
Research Design
Retrospective Studies
SARS-CoV-2
United States
Vaccination
Vaccination

Semantics

Type Source Name
disease MESH COVID-19 pandemic
disease MESH data sources
drug DRUGBANK Trestolone
disease IDO quality
drug DRUGBANK Coenzyme M
drug DRUGBANK Indoleacetic acid
disease MESH emergencies
disease IDO site
disease IDO country
drug DRUGBANK Medical air
disease MESH influenza
disease MESH infections
disease MESH death
disease IDO intervention
disease IDO replication
drug DRUGBANK 5-amino-1 3 4-thiadiazole-2-thiol
disease IDO process
pathway REACTOME Release
disease MESH privacy
pathway REACTOME Translation
disease MESH Infectious Diseases
drug DRUGBANK Delorazepam

Original Article

(Visited 12 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *